Drug development cycles often take months or years, consuming massive manpower and funds. OpenAI’s head of business products, Olivier Godement, spotlights life sciences, software engineering, and customer service as industries on the cusp of AI-driven automation.
Godement points to pharma giants like Amgen, where administrative drag slows innovation. Automating